NRx Pharmaceuticals, Inc. - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
NRXP Nasdaq 8081 www.nrxpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Aug 18th, 2026 6:30 am
NRX Pharmaceuticals Inc (NRXP) (Q2 2026) Earnings Call Highlights: Advancing Ketamine Pipeline ... - Aug 17th, 2026 11:02 pm
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Aug 17th, 2026 1:26 pm
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET - Aug 17th, 2026 5:00 am
NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates - Aug 14th, 2026 6:15 pm
NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles - Aug 10th, 2026 8:04 am
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans - Aug 7th, 2026 2:01 pm
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval - Aug 7th, 2026 5:00 am
Is NRx Pharmaceuticals, Inc. (NRXP) Stock Positioned for Growth Through Depression and PTSD Treatment Innovation? - Jul 15th, 2026 3:21 am
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute - Jun 25th, 2026 2:01 pm
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System - Jun 25th, 2026 5:00 am
Sector Update: Healthcare Stocks Advance Late Afternoon - Jun 24th, 2026 1:32 pm
Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals (NASDAQ: NRXP), Alleging Breach of Contract and Misrepresentation in Connection with Acquisition - Jun 24th, 2026 11:18 am
ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics - Jun 23rd, 2026 9:05 am
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression - Jun 22nd, 2026 5:00 am
NRX Pharmaceuticals Inc (NRXP) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ... - Jun 17th, 2026 4:19 pm
NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offering of Common Stock At $3.50 Per Share - Jun 10th, 2026 12:22 pm
NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology. - Jun 5th, 2026 6:50 am
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option - Jun 4th, 2026 3:12 pm
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock - Jun 3rd, 2026 6:18 am